Mental Health Medication Use Higher in Recovered COVID-19 Patients
The use of antidepressants and benzodiazepines is higher among patients who survived the acute phase of COVID-19, and that is the case even for some people who were not hospitalized. In fact, a new cohort study finds those patients at much greater risk of mental health conditions than the general public or those recovering from some other illnesses in the past. Read more.
|
Survey Supports Better Reimbursement for Antivirals
Pharmacy groups are turning to the public to bolster the case that they should have a larger role in—and better reimbursement for—dispensing oral antiviral drugs to fight COVID-19. A new survey conducted by Morning Consult indicates that U.S. adults agree with them and hold a very high opinion of how pharmacies have performed during the pandemic. Read more.
|